Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains
Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains
Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains
Submitted by
admin
on June 18, 2015 - 8:44pm
Source:
24/7 Wall St
News Tags:
Synergy Pharmaceuticals
chronic idiopathic constipation
plecanatide
Headline:
Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains
Do Not Allow Advertisers to Use My Personal information
